Human Participant Research Restart Advisory Committee
This committee has been meeting regularly to advise on plans to restart human participant research as the University plans a Phase 1 reopening. The committee includes representatives from the School of Medicine, School of Nursing, Bloomberg School of Public Health, and Homewood.
Role of Committee
- Advise the Vice Dean for Clinical Investigation on the overall phased approach for reopening research with in-person interaction.
- Identify options for a safe restart for human participant research activity including processes for review of study protocols.
- Identify and coordinate guidance for staff training and personal protective equipment for clinical research teams.
Committee Members
| Gail Daumit, MD, MHS, FACP (chair) | Janet Mighty, MBA | Irina Burd, MD, PhD |
| Ellen Mowry, MD | Mike Carducci MD, FACP | Geetanjali Chander, MD MPH |
| Bob Wise, MD | Todd Brown, MD, PhD | Dan Ford, MD, MPH |
| Neil Goldenberg, MD PhD | Janet Heussner | Suzanne Jan De Beur, MD |
| Corinne Keet, MD, MD, PhD | Gregory Kirk, MD, MPH, PhD | Sumati Murli, PhD |
| Joan Pettit, JD | Wendy Post, MD, MS | Katrina Purtell, RN |
| Megan Singleton, JD | Kawsar Talaat, MD | Rachel Thronton, MD, PhD |
| John Toscano, PhD | Ryan Vandrey, PhD | Kala Visvanathan, MD, MHS |
| Cheryl Dennison Himmelfarb, PhD, MSN, RN |